REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 87 filers reported holding REATA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
| Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
| Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
| Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
| Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
| KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
| Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
| MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
| Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |